Research and Development
MSD gets CHMP positive opinion for keytruda to treat advanced lung cancer
June 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing CHMP, EMA, MSD, Merck & Co, keytruda, lung cancer
Novartis signs $150 million deal with Xencor to develop bispecific antibodies
June 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Novartis, Xencor, bispecific antibodies, deal, drug development, drug trial
Takeda to return molecules/ products for Japan to Amgen
June 27, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cancer, Japan, Takeda Pharmaceutical, drug development, drug trial
GW Pharmaceuticals says Phase III trials for Epidiolex to treat rare epilepsy in children shows positive results
June 27, 2016 Research and Development, Sales and Marketing Epidiolex, GW Pharmaceuticals, NDA, US FDA, drug trial, orphan drug
Boehringer Ingelheim says Phase III trials for its Ofev slowed progression of fatal lung disease
June 27, 2016 Research and Development, Sales and Marketing Boehringer Ingelheim, drug trial, idiopathic pulmonary fibrosis, research
Sanofi, Boehringer Ingelheim sign definitive agreements for swap
June 27, 2016 Research and Development, Sales and Marketing Boehringer Ingelheim, Financial, Sanofi, business swap, merger and acquisition
Weekly Movers: Lpath, Paratek, Inovio…
June 27, 2016 Research and Development, Sales and Marketing
Brexit may also create opportunities for UK’s pharmaceutical and medical device industries – report
June 27, 2016 Research and Development, Sales and Marketing
Astellas UK suspended from ABPI for “deception” and other cultural failings
June 24, 2016 Medical Communications, Research and Development, Sales and Marketing ABPI, Astellas, cultural failings
Nice rejects AstraZeneca’s Tagrisso for lung cancer in preliminary recommendation
June 24, 2016 Medical Communications, Research and Development AstraZeneca, CDF, NICE, lung cancer, regulation
“Immediate challenges” for UK pharma post-Brexit, says ABPI
June 24, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, brexit
FDA approves expanded label for Allergan’s Avycaz
June 24, 2016 Medical Communications, Research and Development, Sales and Marketing Allergan, Avycaz, FDA, expanded label
Genmab’s CLL drug gets negative opinion from EMA committee
June 24, 2016 Medical Communications, Research and Development, Sales and Marketing Arzerra, CHMP, CLL, EMA, Genmab, blood cancer
Nice rejects Celgene’s drug to treat blood cancer
June 24, 2016 Medical Communications, Research and Development CDF, Celgene, NICE, Vidaza, blood cancer
Sanofi to add future payments onto Medivation offer, according to reports
June 23, 2016 Research and Development, Sales and Marketing Medivation, Sanofi
